EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance

Edgardo Castro-Pérez iD, Mithalesh Singh iD, Shreyans Sadangi iD, Carmen Mela-Sánchez iD, Vijayasaradhi Setaluri iD

Pigment Cell & Melanoma Research · 2023

DOI: 10.1111/pcmr.13092 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pigment Cell & Melanoma Research, 2023. Verfasst von Edgardo Castro-Pérez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cellular and Molecular Biology of Diseases, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City …. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIAMS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma, a lethal malignancy that arises from melanocytes, exhibits a multiplicity of clinico‐pathologically distinct subtypes in sun‐exposed and non‐sun‐exposed areas. Melanocytes are derived from multipotent neural crest cells and are present in diverse anatomical locations, including skin, eyes, and various mucosal membranes. Tissue‐resident melanocyte stem cells and melanocyte precursors contribute to melanocyte renewal. Elegant studies using mouse genetic models have shown that melanoma can arise from either melanocyte stem cells or differentiated pigment‐producing melanocytes depending on a combination of tissue and anatomical site of origin and activation of oncogenic mutations (or overexpression) and/or the repression in expression or inactivating mutations in tumor suppressors. This variation raises the possibility that different subtypes of human melanomas (even subsets within each subtype) may also be a manifestation of malignancies of distinct cells of origin. Melanoma is known to exhibit phenotypic plasticity and trans‐differentiation (defined as a tendency to differentiate into cell lineages other than the original lineage from which the tumor arose) along vascular and neural lineages. Additionally, stem cell‐like properties such as pseudo‐epithelial‐to‐mesenchymal (EMT‐like) transition and expression of stem cell‐related genes have also been associated with the development of melanoma drug resistance. Recent studies that employed reprogramming melanoma cells to induced pluripotent stem cells have uncovered potential relationships between melanoma plasticity, trans‐differentiation, and drug resistance and implications for cell or origin of human cutaneous melanoma. This review provides a comprehensive summary of the current state of knowledge on melanoma cell of origin and the relationship between tumor cell plasticity and drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsInduced Pluripotent Stem CellsAnimalsMiceHumansCell PlasticityMelanocytesCell DifferentiationDrug ResistanceNeural Crest

Stichwörter der Autor:innen

BRAF/MEK inhibitorsdrug resistancemelanoma cell of originmelanoma plasticity and trans-differentiationmelanoma stem cellsmelanoma-derived iPSC

Autor:innen und Institutionen

  • Center for Cellular and Molecular Biology of Diseases, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), City of Knowledge, Panama City, Panama.
  • Department of Genetics and Molecular Biology, University of Panama, Panama City, Panama.
  • Department of Dermatology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
  • William S. Middleton VA Hospital, Madison, Wisconsin, USA.

ORCID-Profile: Edgardo Castro-Pérez, Mithalesh Singh, Shreyans Sadangi, Carmen Mela-Sánchez, Vijayasaradhi Setaluri

Förderung

  • BLRD VA
  • NIAMS NIH HHS
  • NCI NIH HHS

Zitieren

APA

Castro-Pérez, E., Singh, M., Sadangi, S., Mela-Sánchez, C., & Setaluri, V. (2023). Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.13092

Vancouver

Castro-Pérez E, Singh M, Sadangi S, Mela-Sánchez C, Setaluri V. Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance. Pigment Cell & Melanoma Research. 2023. doi:10.1111/pcmr.13092

BibTeX
@article{CastroPrez2023,
  author = {Castro-Pérez, Edgardo and Singh, Mithalesh and Sadangi, Shreyans and Mela-Sánchez, Carmen and Setaluri, Vijayasaradhi},
  title = {Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance},
  journal = {Pigment Cell & Melanoma Research},
  year = {2023},
  doi = {10.1111/pcmr.13092}
}
Kostenlos starten →